Table 4.

Statistical analysis of ICAM-1 and CD105 expression in regenerated mucosa (M ± SEM, n = 8).

	ICAM-1	CD105
Normal control group	181.88 ± 23.62##	16.75 ± 11.26###
UC model group	3100.33 ± 916.65∗∗∗	2268.44 ± 353.60∗∗∗
Low-dose Garidisan group	1225.00 ± 215.24∗∗∗###	1376.50 ± 296.56∗∗∗###
Moderate-dose Garidisan group	1362.38 ± 258.00∗∗∗###	591.38 ± 257.68∗∗∗###
High-dose Garidisan group	976.25 ± 166.67∗∗∗###	606.88 ± 202.88∗∗∗###
Sulfasalazine group	1319.75 ± 360.07∗∗∗###	863.25 ± 420.16∗∗∗###
Bupiyichangwan group	2179.00 ± 514.59∗∗∗###	1617.88 ± 450.23∗∗∗###

P < 0.05, P < 0.01, and ^∗∗∗P < 0.001 compared with normal controls; P < 0.05, ^##P < 0.01, and ^###P < 0.001 compared with the UC model group.